Jane V. Thomas

450 total citations
15 papers, 123 citations indexed

About

Jane V. Thomas is a scholar working on Oncology, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, Jane V. Thomas has authored 15 papers receiving a total of 123 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 7 papers in Surgery and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Jane V. Thomas's work include Colorectal Cancer Treatments and Studies (9 papers), Genetic factors in colorectal cancer (7 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Jane V. Thomas is often cited by papers focused on Colorectal Cancer Treatments and Studies (9 papers), Genetic factors in colorectal cancer (7 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Jane V. Thomas collaborates with scholars based in United States, France and Israel. Jane V. Thomas's co-authors include Michael J. Overman, Alexis D. Leal, Scott Kopetz, Yann Parc, Magali Svrcek, George J. Chang, Romain Cohen, Wai Chin Foo, Raphaël Colle and Thierry André and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Jane V. Thomas

13 papers receiving 120 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jane V. Thomas United States 5 87 51 48 34 25 15 123
Giovanna Sabella Italy 6 86 1.0× 28 0.5× 59 1.2× 62 1.8× 28 1.1× 23 139
Federica Palermo Italy 4 67 0.8× 34 0.7× 50 1.0× 69 2.0× 31 1.2× 12 110
Hans Pruijt Netherlands 6 72 0.8× 42 0.8× 32 0.7× 47 1.4× 15 0.6× 15 128
Maria Kuiper Netherlands 3 86 1.0× 38 0.7× 21 0.4× 40 1.2× 9 0.4× 5 104
Hirokazu Mizuguchi United States 7 92 1.1× 34 0.7× 25 0.5× 57 1.7× 16 0.6× 11 145
Stefan Angermeier Germany 6 94 1.1× 24 0.5× 98 2.0× 138 4.1× 60 2.4× 28 182
Brittanie M Millang United States 7 78 0.9× 12 0.2× 58 1.2× 54 1.6× 16 0.6× 8 115
Mohammad Aburahmah Saudi Arabia 4 44 0.5× 64 1.3× 72 1.5× 80 2.4× 25 1.0× 9 129
Cláudio Rolim Teixeira Brazil 8 158 1.8× 65 1.3× 75 1.6× 103 3.0× 9 0.4× 13 216

Countries citing papers authored by Jane V. Thomas

Since Specialization
Citations

This map shows the geographic impact of Jane V. Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane V. Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane V. Thomas more than expected).

Fields of papers citing papers by Jane V. Thomas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jane V. Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane V. Thomas. The network helps show where Jane V. Thomas may publish in the future.

Co-authorship network of co-authors of Jane V. Thomas

This figure shows the co-authorship network connecting the top 25 collaborators of Jane V. Thomas. A scholar is included among the top collaborators of Jane V. Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jane V. Thomas. Jane V. Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Qiao, Wei, Keyur Patel, Deepak Bhamidipati, et al.. (2025). Long-Term Efficacy of Pembrolizumab and the Clinical Utility of ctDNA in Locally Advanced dMMR/MSI-H Solid Tumors. Nature Communications. 16(1). 4514–4514. 1 indexed citations
2.
Qiao, Wei, F. Anthony San Lucas, Keyur Patel, et al.. (2025). Prognostic value of circulating tumor DNA for progression-free survival in patients with locally advanced dMMR/MSI-H colorectal cancer managed without surgery.. Journal of Clinical Oncology. 43(4_suppl). 256–256. 1 indexed citations
3.
Anandappa, Gayathri, Amjad H. Talukder, Sarah M. Shin, et al.. (2025). Abstract CT012: Personalized neoantigen vaccine with or without pembrolizumab in patients with microsatellite-stable metastatic colorectal cancer. Cancer Research. 85(8_Supplement_2). CT012–CT012. 1 indexed citations
4.
Thomas, Jane V., Kaysia Ludford, Jason Willis, et al.. (2023). Sustained Disease Control in Immune Checkpoint Blockade Responders with Microsatellite Instability-high Colorectal Cancer after Treatment Termination. Cancer Research Communications. 3(12). 2510–2517. 4 indexed citations
5.
Konishi, Tsuyoshi, Harmeet Kaur, Y. Nancy You, et al.. (2023). Immunotherapy for localized MSI-H colorectal cancer: Characterizing endoscopic and imaging response.. Journal of Clinical Oncology. 41(16_suppl). 3610–3610. 1 indexed citations
6.
Stemmer, Amos, Ofer Margalit, Jane V. Thomas, et al.. (2023). Immunotherapy in mismatch repair-deficient metastatic colorectal cancer – Outcome and novel predictive markers. European Journal of Cancer. 198. 113495–113495. 5 indexed citations
7.
Ludford, Kaysia, Kanwal Raghav, Mariela A. Blum Murphy, et al.. (2021). Safety and efficacy of neoadjuvant pembrolizumab in mismatch repair deficient localized/locally advanced solid tumors.. Journal of Clinical Oncology. 39(15_suppl). 2520–2520. 8 indexed citations
8.
Ling, Diane C., Jane V. Thomas, John A. Vargo, et al.. (2020). PET-CT Directed IMRT-based Chemoradiation for Locally Advanced Vulvar Cancer - Analysis of Regional Recurrence Patterns. International Journal of Radiation Oncology*Biology*Physics. 108(3). e469–e469. 2 indexed citations
9.
Thomas, Jane V., Alexis D. Leal, & Michael J. Overman. (2020). Clinical Development of Immunotherapy for Deficient Mismatch Repair Colorectal Cancer. Clinical Colorectal Cancer. 19(2). 73–81. 34 indexed citations
10.
Hwang, Hyunsoo, Huamin Wang, Matthew H. G. Katz, et al.. (2020). Natural history and prognostic factors for localised small bowel adenocarcinoma. ESMO Open. 5(6). e000960–e000960. 21 indexed citations
11.
Johnson, Benny, Jane V. Thomas, Arvind Dasari, et al.. (2020). A phase II study of durvalumab (MEDI4736) (anti-PD-L1) and trametinib (MEKi) in microsatellite stable (MSS) metastatic colorectal cancer (mCRC).. Journal of Clinical Oncology. 38(4_suppl). 152–152. 1 indexed citations
12.
Raghav, Kanwal, Matthew H. G. Katz, Prajnan Das, et al.. (2020). Pattern of recurrence after curative resection of stage I-III duodenal adenocarcinoma.. Journal of Clinical Oncology. 38(4_suppl). 794–794.
13.
Ludford, Kaysia, Romain Cohen, Magali Svrcek, et al.. (2020). Pathological Tumor Response Following Immune Checkpoint Blockade for Deficient Mismatch Repair Advanced Colorectal Cancer. JNCI Journal of the National Cancer Institute. 113(2). 208–211. 42 indexed citations
14.
Ludford, Kaysia, Romain Cohen, Wai Chin Foo, et al.. (2019). Evaluation of complete pathological remission rates in surgically resected MSI-high metastatic colorectal cancers (mCRC).. Journal of Clinical Oncology. 37(15_suppl). e15046–e15046.
15.
Raphael, Simon, et al.. (1993). Pancreatic xanthomatous neuropathy associated with hyperlipidemia: A cause of abdominal pain mimicking chronic pancreatitis. Human Pathology. 24(9). 1023–1025. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Giovanna Sabella Breakdown of academic impact, for papers by Federica Palermo Breakdown of academic impact, for papers by Hans Pruijt Breakdown of academic impact, for papers by Maria Kuiper Breakdown of academic impact, for papers by Hirokazu Mizuguchi Breakdown of academic impact, for papers by Stefan Angermeier Breakdown of academic impact, for papers by Brittanie M Millang Breakdown of academic impact, for papers by Mohammad Aburahmah Breakdown of academic impact, for papers by Cláudio Rolim Teixeira
Rankless by CCL
2026